Application of FAPI-PET/CT in diagnosis and staging of nasopharyngeal carcinoma and GTV target volume delineation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300074538

Enrollment

Unknown

Registered

2023-08-09

Start date

2022-08-01

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

FAPI group:None

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Patients were pathologically diagnosed with nasopharyngeal carcinoma at West China Hospital of Sichuan University; 2) Patients who have not received anti-tumor treatment in the previous four weeks.

Exclusion criteria

Exclusion criteria: 1)Patients with other primary malignant diseases; 2) Patients who have a history of neck surgery; 3) Patients who have hyperglycemia or severe liver and kidney dysfunction.4) Contraindication to CT.

Design outcomes

Primary

Measure	Time frame
The accuracy of FAPI-PET/CT delineation of GTV;Sensitivity of staging;	—

Secondary

Measure	Time frame
The accuracy of FDG-PET/CT delineation of GTV;	—

Countries

China

Contacts

Public ContactXingchen Peng

West China Hospital, Sichuan University

pengxingchen@wchscu.cn+86 189 8060 6753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026